SCHEMBL16614068

SCHEMBL16614068

Cc1cc(C)cc(-c2nc(-c3ccccc3)cc(-c3ccccc3)n2)c1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 11/20 0.60
KMT2A Q03164 11/20 0.60
MAPT P10636 9/20 0.60
ALDH1A1 P00352 7/20 0.60
HPGD P15428 6/20 0.60
KDM4E B2RXH2 5/20 0.56
L3MBTL1 Q9Y468 4/20 0.56
LMNA P02545 3/20 0.56
TDP1 Q9NUW8 2/20 0.56
NTSR1 P30989 1/20 0.55
ADORA2A P29274 2/20 0.52
ADORA1 P30542 2/20 0.52
SMN1; SMN2 Q16637 1/20 0.52
TSHR P16473 1/20 0.52
ATM Q13315 1/20 0.52
GLA P06280 1/20 0.51
AGTR1 P30556 1/20 0.51
TP53 P04637 1/20 0.51
NPSR1 Q6W5P4 2/20 0.49
MAPK1 P28482 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20251432 0.98 MEN1 (0.58) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL18267903 0.94 MEN1 (0.63) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL18267899 0.92 MEN1 (0.53) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL4546904 0.92 MEN1 (0.60) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL16688028 0.91 MEN1 (0.62) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL10128416 0.87 MEN1 (0.62) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL15748741 0.87 MEN1 (0.57) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL10128387 0.87 MEN1 (0.56) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL4546933 0.87 L3MBTL1 (0.64) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL16407477 0.87 L3MBTL1 (0.64) MEN1KMT2AMAPTALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10008675-B2 Organic compound and organic electroluminescent element comprising same DOOSAN CORPORATION (KR) 2018-06-26 US disclosed
US-9780310-B2 Heterocyclic compound for organic electroluminescent device and its application TOSOH CORPORATION (JP) 2017-10-03 US disclosed
US-20160351825-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT ELEMENT COMPRISING SAME DOOSAN CORPORATION (KR) 2016-12-01 US disclosed
WO-2015047018-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT ELEMENT COMPRISING SAME 주식회사 두산 2015-04-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160351825-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT ELEMENT COMPRISING SAME OR10J3, ORAI2, ETV6 MEN1 2331/4885KMT2A 1517/4885MAPT 1043/4885
US-10008675-B2 Organic compound and organic electroluminescent element comprising same OR10J3, ORAI2, ETV6 MEN1 2331/4885KMT2A 1517/4885MAPT 1043/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.